Vogt-koyanagi-harada -like</i> disease following yellow fever vaccination
| dc.creator | Wesley Ribeiro Campos | |
| dc.creator | Sarah p. f. Cenachi | |
| dc.creator | Matheus Schmidt Soares | |
| dc.creator | Priscila Freitas Gonçalves | |
| dc.creator | Daniel v. Vasconcelos-santos | |
| dc.date.accessioned | 2023-06-07T19:17:29Z | |
| dc.date.accessioned | 2025-09-08T22:50:00Z | |
| dc.date.available | 2023-06-07T19:17:29Z | |
| dc.date.issued | 2019-10-11 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.1080/09273948.2019.1661498 | |
| dc.identifier.issn | 09273948 | |
| dc.identifier.uri | https://hdl.handle.net/1843/54665 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Ocular Immunology and Inflammation | |
| dc.rights | Acesso Restrito | |
| dc.subject | Síndrome Uveomeningoencefálica | |
| dc.subject | Coroidite | |
| dc.subject | Uveite | |
| dc.subject | Vacina contra Febre Amarela | |
| dc.subject.other | Coroidite | |
| dc.subject.other | Síndrome de Vogt-Koyanagi-Harada | |
| dc.subject.other | Uveite | |
| dc.subject.other | Vacina febre amarela | |
| dc.title | Vogt-koyanagi-harada -like</i> disease following yellow fever vaccination | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 127 | |
| local.citation.issue | 1 | |
| local.citation.spage | 124 | |
| local.citation.volume | 29 | |
| local.description.resumo | Purpose: To report the manifestation of Vogt–Koyanagi–Harada-like disease (VKH) following yellow fever vaccination. Methods: Case report. Results: A 34-year-old immunocompetent male had tinnitus, headache, and decreased vision after a booster dose of yellow fever vaccine. Visual acuity was 20/100 in the right eye and 20/80 in the left, with serous retinal detachment (SRD) and choroidal thickening identified on clinical examination and multimodal imaging. Lumbar puncture revealed pleocytosis and an increased protein content, but extensive investigations ruled out infectious/ neurological diseases. Pulse intravenous methylprednisolone was given, followed by a tapering regimen of highdose oral prednisone. Azathioprine was started early, 3 weeks after initiation of oral steroids. Intraocular inflammation and SRD rapidly resolved, with visual acuity reaching 20/20 in both eyes, after 3 weeks. No recurrence of intraocular inflammation or sign of depigmentation was so far noticed, at 2 years of follow-up. Conclusion: Yellow fever vaccine may be a possible trigger for VKH. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE OFTALMOLOGIA E OTORRINOLARINGOLOGIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.tandfonline.com/doi/full/10.1080/09273948.2019.1661498 |
Arquivos
Licença do pacote
1 - 1 de 1